Originally published by our sister publication Specialty Pharmacy Continuum
By Ethan Covey
Identifying patients with rheumatoid arthritis (RA) who may be at risk for nonadherence to treatment and targeting them via pharmacist-led interventions may reduce their risk—and even address nonadherence before it occurs.
The results of a study on predicting nonadherence with RA treatment were presented at the NASP 2024 Annual Meeting & Expo, in Nashville, Tenn.
People with RA can experience